VectorY
Passionate about re-engineering viruses to serve instead of to strike, Dr. Barbara Sanders has dedicated the last decade of her career to the Viral Vector Development arena within large pharma and biotech. During these years she led multiple Discovery Teams within Vector Development to successfully design & develop several viral vectored candidates which are currently in the clinic.
VectorY
VectorY combines the therapeutic potential of antibodies and gene therapy to develop long-lasting therapeutic solutions for large disease areas of high unmet medical need. By combining state-of-the-art technologies and novel and scientific concepts, VectorY’s mission is to bring innovative therapies to patients worldwide.